The Senate Committee on Health, Education, Labor, and Pensions has announced that Novo Nordisk CEO Lars Jorgensen will voluntarily testify about the high U.S. prices for weight loss drugs Ozempic and Wegovy. This decision cancels a scheduled vote to subpoena Novo's president Doug Langa. The hearing will discuss why these drugs are significantly more expensive in the U.S. compared to other countries.
(Reuters) -The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk CEO Lars Jorgensen has agreed to testify voluntarily in a hearing focusing on U.S.
This week in Other Barks and Bites: the D.C. Court of Appeals finds that the Administrative Procedures Act waives sovereign immunity in the context of copyright rule promulgation; the U.S. Chamber of Commerce calls out Bernie Sanders for abusive subpoenas targeting a pharmaceutical executive at Novo Nordisk; and more.
Senate Panel to Vote on Subpoena for Ozempic Maker Executive theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.